⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RADX News
Radiopharm Theranostics Limited American Depositary Shares
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01) USA - English USA - Français USA - Deutsch
prnewswire.com
RADX
AtomVie Global Radiopharma suministra la primera dosis en el estudio clínico de Radiopharm Theranostics USA - español USA - Français USA - Deutsch USA - English APAC - English USA - English
prnewswire.com
RADX
AtomVie Global Radiopharma fournit la première dose à un patient dans le cadre de l'étude clinique de phase 1/2a de Radiopharm Theranostics sur le 177Lu-BetaBart (RV-01) USA - Français USA - Deutsch USA - English
prnewswire.com
RADX
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01) USA - English USA - Français USA - Deutsch USA - English APAC - English
prnewswire.com
RADX
AtomVie Global Radiopharma liefert erste Patientendosis in Phase 1/2a der klinischen Studie von Radiopharm Theranostics mit 177Lu-BetaBart (RV-01) USA - Deutsch USA - English USA - Français
prnewswire.com
RADX
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
globenewswire.com
RADX
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates
globenewswire.com
RADX
Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
globenewswire.com
RADX
OPHC
DGXX
CLNN
DEVS
ZENA
IMRN
MIGI
TIVC
SBC
Presenting on Emerging Growth Conference 89 Day 2 on January 22; Register to live stream
globenewswire.com
RADX
OPHC
DGXX
CLNN
DEVS
ZENA
IMRN
MIGI
TIVC
SBC
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream
globenewswire.com
RADX
OPHC
DEVS
CLNN
DGXX
ZENA
IMRN
MIGI
TIVC
SBC